Author

Jiang-Bo Lin

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic Stratification of Adjuvant Immunotherapy After Neoadjuvant Chemoimmunotherapy and Quality Surgery in LA-ESCC.

BACKGROUND In locally advanced esophageal squamous cell carcinoma (LA-ESCC), neoadjuvant chemoimmunotherapy (NCIT) plus high-quality surgery (R0 resection with systematic lymphadenectomy >19 nodes) is a promising strategy. However, the value of adjuvant immunotherapy remains unclear. This study aimed to evaluate the as...

Jing-Wei Sun, Pei-Long Bao, Yu-Quan Bai et al. · Journal of Thoracic and Card... · 0 citations

Open access Sep 2026

Early recurrence patterns after neoadjuvant chemoradiotherapy and chemoimmunotherapy in esophageal squamous cell carcinoma: A multicenter study.

OBJECTIVE To compare early recurrence patterns and survival outcomes between neoadjuvant chemoimmunotherapy (NCIT) and neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). METHODS This retrospective cohort study included 1428 patients with stage IIB-IVA ESC...

Ci-En Sun, Chun-Ji Chen, Hua Sun et al. · European Journal of Cardio-T... · 0 citations

Open access Oct 2026

Efficacy comparison of neoadjuvant chemotherapy, chemoradiotherapy, and chemoimmunotherapy in resectable esophageal squamous cell carcinoma: short- and long-term outcomes from a propensity score-matched analysis

This study consecutively enrolled patients with resectable locally advanced esophageal squamous cell carcinoma (ESCC) treated at Fujian Medical University Union Hospital and Gaozhou People's Hospital between January 1, 2,019, and January 1, 2022. All patients received neoadjuvant therapy followed by minimall...

Hai Zhang, Yun Liang, Chao-Lin Li et al. · Frontiers in Medicine · 0 citations